Tenax Therapeutics
TENX
6 hedge funds and large institutions have $1.1M invested in Tenax Therapeutics in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
164% more capital inflows, than outflows
Capital inflows: $182K | Capital outflows: $69K
0.73% more ownership
Funds ownership: 11.25% → 11.98% (+0.73%)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$162K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$10.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
-$69K |
TENX Hedge Fund Activity: Q2 2018 in Review
6 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2018, worth a combined $1.1M — up 27% from $866K a quarter earlier.
Fund positioning in TENX was balanced in Q2 2018: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $162K. The largest seller was Virtu Financial, exiting entirely with an estimated $69K sold.
- 6 institutional investors held Tenax Therapeutics (TENX) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $1.1M of Tenax Therapeutics stock for Q2 2018, up 27% quarter-over-quarter.
- 1 fund opened new Tenax Therapeutics positions in Q2 2018 and 1 closed out, a net change of 0 holders.
- The largest Tenax Therapeutics buyer in Q2 2018 was Renaissance Technologies, an estimated $162K added.
- The largest Tenax Therapeutics seller in Q2 2018 was Virtu Financial, an estimated $69K sold.
Based on aggregated 13F filings for Q2 2018.